Aadi Bioscience inks $44 million deal for exclusive rights to three preclinical ADC programs. Aadi secures $100 million in PIPE financing, selling 21.6 million shares at $2.40 each to support its ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...